Completed
Phase I Study of MEDI522 in Patients With Irinotecan-Refractory Advanced Colorectal Cancer
NCT00284817
- Conditions
- Cancer, Neoplasms
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States